Table 4.
Variable | Study population (n = 69) | p53-MCL positive (n = 2) |
---|---|---|
Age-years | ||
Average | 60.2 | 58 |
Range | 30–77 | 58–63 |
Age onset Breast tumor appearance | ||
Average | 49.1 | 48 |
Range | 25–70 | 48–51 |
Breast tumor Diagnosis | ||
Ductal | 59 (85.5 %) | 1 (50 %) |
Lobular | 3 (4.3 %) | 0 |
Unknown | 7 (10.2 %) | 1 (50 %) |
ER status | ||
Negative | 17 (24.6 %) | 0 |
Positive | 34 (49.3 %) | 2 (100 %) |
Unknown | 18 (26.1 %) | 0 |
PgR status | ||
Negative | 17 (24.6 %) | 0 |
Positive | 34 (49.3 %) | 2 (100 %) |
Unknown | 18 (26.1 %) | 0 |
ER estrogen receptor, PgR progesterone receptor